Remdesivir gets lukewarm endorsement from experts in Covid fight1 min read 31 Jul 2020, 05:52 AM IST
Remdesivir may be effective in reducing recovery time in patients with severe Covid-19, though more trials are needed to confirm this, the experts said
The effectiveness of most interventions with remdesivir is uncertain
Gilead Sciences Inc.’s remdesivir is worth prescribing for patients with severe Covid-19 though evidence of its benefits remains inconclusive, according to a panel of international experts convened by the British Medical Journal.
Select your Category